Hutecs Korea Pharmaceutical throws a winning bid in the hyperlipidemia treatment pitavastatin market represented by the original drug Livalo.

As the 21st latecomer introduced to the market, Hutecs’ generic is putting pressure on other competitor companies, being listed at a price lower than 85% of the current lowest price.

According to industry sources on the 26th, Hutecs succeeded in listing both Lovalow 1mg and Lovalow 4mg with reimbursement.

The ceiling price was set at KRW 295 for the Lovalow 1mg, and KRW 527 for Lovalow 4mg. The two products are both listed at the lowest price among the listed products.

In particular, the price of Lovalow 4mg was se